Ensuring Excellence: Quality Control of Raw & Starting Materials for mRNA-Based Therapeutics

Time: 11:00 am
day: Day One


  • What specific attributes of mRNA raw materials are evaluated during quality control processes, and how do these attributes influence the safety and efficacy of the final product? 
  • What are the established regulatory guidelines for quality control of mRNA raw materials? 
  • What strategies are being explored to address challenges related to batch-to-batch variability and quality assurance?